EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis

Hong Ha Nguyen, Cuc Thi Thu Nguyen, Tran Ngoc Phuong Mai, Phung Thanh Huong

Pharmacogenetics and Genomics · 2023

DOI: 10.1097/fpc.0000000000000490 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pharmacogenetics and Genomics, 2023. Verfasst von Hong Ha Nguyen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Biotechnology, Hanoi University of Pharmacy. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Organic Anion Transporters. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Statins are the first-choice therapy for dyslipidemia, but their effectiveness can be influenced by genetic polymorphisms. This study was conducted to assess the association of variants of the solute carrier anion transporter family 1B1 ( SLCO1B1 ) gene, which encodes a transporter involving the hepatic clearance of the statins and their therapeutic efficacy.

Method

A systematic review was performed on four electronic databases to identify relevant studies. The pooled mean difference with 95% confidence interval (CI) in percentage change of concentration of LDL-C, total cholesterol (TC), HDL-C, and triglycerides was calculated. Heterogeneity between studies and publication bias, subgroup analyses, and sensitivity analyses were also carried out using R software.

Results

Twenty-one studies on 24 365 participants and four variants [rs4149056 (c.521T>C), rs2306283 (c.388A>G), rs11045819 (c.463C>A), rs4363657 (g.89595T>C)] were analyzed. A statistically significant association was found between the LDL-C-lowering effectiveness and the rs4149056 and rs11045819 in the heterozygote model; and the rs4149056, rs2306283, and rs11045819 in the homozygote model. In the subgroup analyses, non-Asian populations, simvastatin, and pravastatin showed significant associations between LDL-C-lowering efficacy and the rs4149056 or rs2306283. Significant associations between the rs2306283 and HDL-C-increasing effectiveness were found in the homozygote model. Regarding TC-reducing, significant associations were observed in the heterozygote and homozygote models of the rs11045819. There was no heterogeneity and publication bias among most studies.

Conclusion

SLCO1B1 variants can be used as signals to predict the statins’ effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsOrganic Anion TransportersHumansCholesterol, LDLPolymorphism, Single NucleotideLiver-Specific Organic Anion Transporter 1Simvastatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol, LDLLiver-Specific Organic Anion Transporter 1SimvastatinOrganic Anion TransportersSLCO1B1 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Biotechnology, Hanoi University of Pharmacy.
  • Department of Pharmaceutical Administration and Economics, Faculty of Pharmaceutical Administration and Economics, Hanoi University of Pharmacy.
  • Department of Public Health, National Institute of Hygiene and Epidemiology, Hanoi 10000, Vietnam.

Zitieren

APA

Nguyen, H. H., Nguyen, C. T. T., Mai, T. N. P., & Huong, P. T. (2023). Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis. Pharmacogenetics and Genomics. https://doi.org/10.1097/fpc.0000000000000490

Vancouver

Nguyen HH, Nguyen CTT, Mai TNP, Huong PT. Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis. Pharmacogenetics and Genomics. 2023. doi:10.1097/fpc.0000000000000490

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Hong Ha and Nguyen, Cuc Thi Thu and Mai, Tran Ngoc Phuong and Huong, Phung Thanh},
  title = {Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis},
  journal = {Pharmacogenetics and Genomics},
  year = {2023},
  doi = {10.1097/fpc.0000000000000490}
}
Kostenlos starten →